| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3716839
Max Phase: Preclinical
Molecular Formula: C17H18N4OS
Molecular Weight: 326.43
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: O=C(NC1CCCNC1)c1ccnc2[nH]c(-c3cccs3)cc12
Standard InChI: InChI=1S/C17H18N4OS/c22-17(20-11-3-1-6-18-10-11)12-5-7-19-16-13(12)9-14(21-16)15-4-2-8-23-15/h2,4-5,7-9,11,18H,1,3,6,10H2,(H,19,21)(H,20,22)
Standard InChI Key: CXENIFXVIZIBQT-UHFFFAOYSA-N
Associated Targets(Human)
PDZ-binding kinase 995 Activities
T47D 39041 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
HT1197 222 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 326.43 | Molecular Weight (Monoisotopic): 326.1201 | AlogP: 2.77 | #Rotatable Bonds: 3 |
| Polar Surface Area: 69.81 | Molecular Species: BASE | HBA: 4 | HBD: 3 |
| #RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 12.70 | CX Basic pKa: 9.42 | CX LogP: 1.74 | CX LogD: -0.35 |
| Aromatic Rings: 3 | Heavy Atoms: 23 | QED Weighted: 0.69 | Np Likeness Score: -1.23 |
References
| 1. (2011) Imidazopyridine derivatives and pbk inhibitors containing the same, |
Source
Source(1):